CarcinoS is not an AI curation engine.
Oncology updates pass through a deterministic ingestion and scoring pipeline, with AI used selectively where it adds value. Every practice-impacting update is ultimately reviewed by a human editor before reaching clinicians.
Deterministic first. AI-assisted. Human reviewed.
Developed by a practicing Oncologist · Free during early access
Why We Built CarcinoS
We designed CarcinoS out of a passion for medical education and a desire to support clinicians already burdened by an increasingly complex healthcare system.
CarcinoS works quietly in the background—identifying and delivering the findings that truly matter without asking clinicians to continually search for them.
Our goal is to make staying informed nearly effortless, reduce information overload, and help clinicians committed to providing the best and most up-to-date care for their patients continue to do so.
Jeffrey Brower, MD, PhD
Founder, CarcinoS
Live digest
See what CarcinoS surfaces this week
Browse the current week's curated oncology updates — no account required.
View this week's digest →Staying current in oncology is a challenge. CarcinoS allows me to focus on patient care while feeling confident I'm not missing the few updates that actually impact my patients.
Radiation Oncologist · Academic Medical CenterThe best part of CarcinoS is its focus on what is truly salient to my current practice, rather than filling the feed with random, low-value articles. The updates are concise, and the organized, searchable archive makes it easy to go back and find important developments from prior months.
Medical Oncologist · Academic Cancer CenterCarcinoS complements tools like OpenEvidence. Rather than simply providing quick answers, CarcinoS helps physicians stay informed, engaged with new evidence, and continue learning for themselves.
Radiation Oncologist · Community Cancer CenterCarcino S surfaces and curates what matters
Rules-based pipeline. Human editorial judgment. No AI black boxes.
Carcino S is built on a deterministic ingestion pipeline. AI assists with synthesis. A practicing oncologist holds final editorial authority over every alert.
Notifications are reserved exclusively
for practice-impacting evidence
Everything you need to know before signing up.
CarcinoS delivers curated weekly updates on the website covering the prior week's oncology literature. Email notifications are reserved for practice-impacting findings and will only be sent to your email when qualifying evidence emerges.
CarcinoS covers all major solid tumor oncology specialties including lung, breast, gastrointestinal, genitourinary, CNS, head & neck, gynecologic, melanoma, sarcoma, and hepatobiliary cancers. Coverage expands continuously.
No. CarcinoS monitors the published oncology literature only. No patient records, clinical notes, or identifiable health information of any kind are ever collected or processed.
AI-assisted triage identifies and scores candidate papers against a structured clinical relevance framework. All tier assignments are reviewed with human editorial oversight from practicing oncologists before publication in the digest.